TIPE2 as a potential therapeutic target in chronic viral hepatitis

References

• Padmavathi G, Banik K, Monisha J, et al. Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: functions and downstream targets involved in cancer progression. Cancer Lett. 2018 Sep 28;432:260–271.
   PubMed Web of Science ®Google Scholar
• Han Y, Tang Z, Zhao Y, et al. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Mol Carcinog. 2018 Feb;57(2):159–166.
   PubMed Web of Science ®Google Scholar
• Xiao M, Xu Q, Lou C, et al. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Hum Pathol. 2017;62:40–49.
   PubMed Web of Science ®Google Scholar
• Freundt EC, Bidere N, Lenardo MJ. A different TIPE of immune homeostasis. Cell. 2008 May 2;133(3):401–402.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen Y, Xie H, et al. TIPE1 suppresses invasion and migration through down-regulating Wnt/beta-catenin pathway in gastric cancer. J Cell Mol Med. 2018 Feb;22(2):1103–1117.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen C, Feng S, et al. TIPE2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3kinase/AKT signaling pathway. Mol Med Rep. 2018 May;17(5):7017–7026.
   PubMed Web of Science ®Google Scholar
• Zhao P, Pang X, Jiang J, et al. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome. Carcinogenesis. 2018.
   Web of Science ®Google Scholar
• Bordoloi D, Banik K, Shabnam B, et al. TIPE family of proteins and its implications in different chronic diseases. Int J Mol Sci. 2018 Sep 29;19(10).
   PubMed Web of Science ®Google Scholar
• Lian K, Ma C, Hao C, et al. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-kappaB signaling pathways. Oncotarget. 2017 Jul 25;8(30):48889–48904.
   PubMedGoogle Scholar
• Ren XY, Wen X, Li YQ, et al. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2018 Sep 14;37(1):227.
   PubMed Web of Science ®Google Scholar
• Wang G, Guo C, Zhao H, et al. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location. BMC Cancer. 2018 Mar 6;18(1):260.
   PubMedGoogle Scholar
• Yuan F, Liu B, Xu Y, et al. TIPE3 is a regulator of cell apoptosis in glioblastoma. Cancer Lett. 2019 Apr 1;446:1–14.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang X, Yang X, et al. Association between the expression levels of tumor necrosis factor-alpha-induced protein 8 and the prognosis of patients with gastric adenocarcinoma. Exp Ther Med. 2016 Jul;12(1):238–244.
   PubMed Web of Science ®Google Scholar
• Shi TY, Cheng X, Yu KD, et al. Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Carcinogenesis. 2013 Apr;34(4):770–778.
   PubMed Web of Science ®Google Scholar
• Wang J, Gao H, Liu G, et al. Tumor necrosis factor alpha-induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapy. Hum Pathol. 2018;82:239–248.
   PubMed Web of Science ®Google Scholar
• Xing Y, Liu Y, Liu T, et al. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway. Cell Commun Signal. 2018 Jul 31;16(1):43.
   PubMedGoogle Scholar
• Zhang L, Liu R, Luan YY, et al. Tumor necrosis factor-alpha induced protein 8: pathophysiology, clinical significance, and regulatory mechanism. Int J Biol Sci. 2018;14(4):398–405.
   PubMed Web of Science ®Google Scholar
• Liu T, Gao H, Chen X, et al. TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer. Br J Cancer. 2013 Sep 17;109(6):1685–1692.
   PubMed Web of Science ®Google Scholar
• Zhang C, Kallakury BV, Ross JS, et al. The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. Int J Cancer. 2013 Jul 1;133(1):31–42.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen M-B, Zhou X-Y, et al. Lymphotoxin alpha (LTA) Polymorphism is associated with prognosis of non-hodgkin‘s lymphoma in a chinese population. PloS One. 2013 20;8(6):Jun.
   Web of Science ®Google Scholar
• Wu X, Ma Y, Cheng J, et al. TIPE1 function as a prognosis predictor and negative regulator of lung cancer. Oncotarget. 2017 Oct 3;8(45):78496–78506.
   PubMedGoogle Scholar
• Zhang Z, Liang X, Gao L, et al. TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells. Oncogene. 2015 May 14;34(20):2566–2574.
   PubMed Web of Science ®Google Scholar
• Cui J, Zhang GZ, Hao CY, et al. The expression of TIPE1 in murine tissues and human cell lines. Mol Immunol. 2011 Jul;48(12–13):1548–1555.
   PubMed Web of Science ®Google Scholar
• Li X. TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma. Tumour Biol. 2016 Apr;37(4):5585–5590.
   PubMedGoogle Scholar
• Shi-Bai Z, Rui-Min L, Ying-Chuan S, et al. TIPE2 expression is increased in peripheral blood mononuclear cells from patients with rheumatoid arthritis. Oncotarget. 2017 Oct 20;8(50):87472–87479.
   PubMedGoogle Scholar
• Zhang YY, Huang NN, Fan YC, et al. Peripheral tumor necrosis factor-a-induced protein 8-like 2 mRNA level for predicting 3-month mortality of patients with acute ischemic stroke. J Neurol. 2018 Nov;265(11):2573–2586.
   PubMed Web of Science ®Google Scholar
• Fayngerts SA, Wu J, Oxley CL, et al. TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell. 2014 Oct 13;26(4):465–478.
   PubMed Web of Science ®Google Scholar
• Moniz LS, Vanhaesebroeck B. A new TIPE of phosphoinositide regulator in cancer. Cancer Cell. 2014 Oct 13;26(4):443–444.
   PubMed Web of Science ®Google Scholar
• Niture S, Dong X, Arthur E, et al. Oncogenic role of tumor necrosis factor α-induced protein 8 (TNFAIP8). Cells. 2018 Dec 24;8:1.
   Web of Science ®Google Scholar
• Zhang X, Wang J, Fan C, et al. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol. 2009 Jan;16(1):89–90.
   PubMed Web of Science ®Google Scholar
• Hua ZC, Sohn SJ, Kang CH, et al. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity. 2003 Apr;18(4):513–521.
   PubMed Web of Science ®Google Scholar
• Zhang L, Shi Y, Wang Y, et al. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol. 2011 May;48(9–10):1209–1215.
   PubMed Web of Science ®Google Scholar
• Zhang G, Hao C, Lou Y, et al. Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol. 2010 Sep;47(15):2435–2442.
   PubMed Web of Science ®Google Scholar
• Sun H, Gong S, Carmody RJ, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008 May 2;133(3):415–426.
   PubMed Web of Science ®Google Scholar
• Li XM, Su JR, Yan SP, et al. A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8. Cancer Biomarkers. 2014;14(4):233–240.
   PubMed Web of Science ®Google Scholar
• Oho M, Nakano R, Nakayama R, et al. TIPE2 (tumor necrosis factor α-induced protein 8-like 2) is a novel negative regulator of TAK1 signal. J Biol Chem. 2016 Oct 21;291(43):22650–22660.
   PubMed Web of Science ®Google Scholar
• Hinshaw-Makepeace J, Huston G, Fortner KA, et al. c-FLIPs reduces activation of caspase and NF-kappa B pathways and decreases T cell survival. Eur J Immunol. 2008 Jan;38(1):54–63.
   PubMed Web of Science ®Google Scholar
• Misra RS, Russell JQ, Koenig A, et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappa B adaptors during T cell activation. J Biol Chem. 2007 Jul 6;282(27):19365–19374.
   PubMed Web of Science ®Google Scholar
• Salmena L, Hakem R. Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med. 2005 Sep 19;202(6):727–732.
   PubMed Web of Science ®Google Scholar
• Jang E-J, Nahm D-H, Jang Y-J. Mouse monoclonal autoantibodies penetrate mouse macrophage cells and stimulate NF-κB activation and TNF-α release. Immunol Lett. 2009;124(2):70–76.
   PubMed Web of Science ®Google Scholar
• Wang Z, Fayngerts S, Wang P, et al. TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection. Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15413–15418.
   PubMed Web of Science ®Google Scholar
• Goldsmith JR, Fayngerts S, Chen YH. Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins. Cell Mol Immunol. 2017 Jun;14(6):482–487.
   PubMed Web of Science ®Google Scholar
• Antony P, Baby B, Vijayan R. Molecular insights into the binding of phosphoinositides to the TH domain region of TIPE proteins. J Mol Model. 2016 Nov;22(11):272.
   PubMed Web of Science ®Google Scholar
• Gus-Brautbar Y, Johnson D, Zhang L, et al. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell. 2012 Mar 9;45(5):610–618.
   PubMed Web of Science ®Google Scholar
• Cao X, Zhang L, Shi Y, et al. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer. 2013 Nov 26;12:149.
   Web of Science ®Google Scholar
• Ruan Q, Wang P, Wang T, et al. MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2. Cell Death Dis. 2014 Feb 27;5:e1095.
   PubMed Web of Science ®Google Scholar
• Niu J, Shi Y, Tan G, et al. DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem. 2012 Jun 22;287(26):21783–21795.
   PubMed Web of Science ®Google Scholar
• Sun H, Zhuang G, Chai L, et al. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway. J Immunol. 2012 Sep 15;189(6):2768–2773.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li Q, Zhang Y, et al. TIPE2 governs macrophage polarization via negative regulation of mTORC1. Mol Med Rep. 2018 Jan;17(1):952–960.
   PubMed Web of Science ®Google Scholar
• Liu R, Fan T, Geng W, et al. Negative immune regulator TIPE2 promotes M2 macrophage differentiation through the activation of PI3K-AKT signaling pathway. PLoS One. 2017;12(1):e0170666.
   PubMed Web of Science ®Google Scholar
• Fayngerts SA, Wang Z, Zamani A, et al. Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein TIPE2. Nat Immunol. 2017 Dec;18(12):1353–1360.
   PubMed Web of Science ®Google Scholar
• Lou Y, Zhang G, Geng M, et al. TIPE2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase. PloS One. 2014;9(5):e96508.
   PubMed Web of Science ®Google Scholar
• Lou Y, Liu S, Zhang C, et al. Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein. J Iimmunol. 2013 Nov 1;191(9):4849–4857.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu T, Liu W, et al. TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury. J Mol Med (Berl). 2015 Sep;93(9):1033–1043.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shao Z, Zhang X, et al. TIPE2 play a negative role in TLR4-mediated autoimmune T helper 17 cell responses in patients with myasthenia gravis. J Neuroimmune Pharmacol. 2015 Dec;10(4):635–644.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu L, Cao S, et al. Gene delivery of TIPE2 inhibits breast cancer development and metastasis via CD8(+) T and NK cell-mediated antitumor responses. Mol Immunol. 2017;85:230–237.
   PubMed Web of Science ®Google Scholar
• Whibley N, Tucci A, Powrie F. Regulatory T cell adaptation in the intestine and skin. Nat Immunol. 2019 Apr;20(4):386–396.
   PubMed Web of Science ®Google Scholar
• Wing JB, Tekguc M, Sakaguchi S. Control of germinal center responses by T-follicular regulatory cells. Front Immunol. 2018;9:1910.
   PubMed Web of Science ®Google Scholar
• Luan YY, Yao YM, Zhang L, et al. Expression of tumor necrosis factor-alpha induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Mol Immunol. 2011 Oct;49(1–2):219–226.
   PubMed Web of Science ®Google Scholar
• Fan T, Huang X, Liu C, et al. Egress of murine regulatory T cells from the thymus requires TIPE2. Biochem Biophys Res Commun. 2018 Jun 2;500(2):376–383.
   PubMed Web of Science ®Google Scholar
• Liu R, Liu C, Liu C, et al. TIPE2 in dendritic cells inhibits the induction of pTregs in the gut mucosa. Biochem Biophys Res Commun. 2019 Feb 19;509(4):911–917.
   PubMed Web of Science ®Google Scholar
• Rehermann B, Bertoletti A. Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections. Hepatology. 2015 Feb;61(2):712–721.
   PubMed Web of Science ®Google Scholar
• Rehermann B, Thimme R. Insights from antiviral therapy into immune responses to hepatitis B and C virus infection. Gastroenterology. 2019 Jan;156(2):369–383.
   PubMed Web of Science ®Google Scholar
• Xi WJ, Hu YJ, Liu YG, et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol. 2011 May;48(9–10):1203–1208.
   PubMed Web of Science ®Google Scholar
• Kong L, Liu K, Zhang Y-Z, et al. Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C. Hepatol Int. 2013 7;Jul(3):844–849.
   Google Scholar
• Xu DD, Li XF, Li YH, et al. TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells. Biochem Biophys Res Commun. 2018 Mar 25;498(1):199–206.
   PubMed Web of Science ®Google Scholar
• Zhang YH, Yan HQ, Wang F, et al. TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation. Int J Oncol. 2015 Jan;46(1):254–264.
   PubMed Web of Science ®Google Scholar
• Fan YC, Zhang YY, Wang N, et al. Tumor necrosis factor-alpha-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B. Oncotarget. 2017 May 9;8(19):30781–30792.
   PubMedGoogle Scholar
• Peng Y, Zhao Q, Zhang H, et al. TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling. Oncol Rep. 2016 Apr;35(4):2480–2486.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang J, Zhao L, et al. TIPE2 protein negatively regulates HBV-specific CD8+ T lymphocyte functions in humans. Mol Immunol. 2015;64(1):204–209.
   PubMed Web of Science ®Google Scholar
• Zhang J-Y, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010 Jan;51(1):81–91.
   PubMed Web of Science ®Google Scholar
• Sun HQ, Zhang JY, Zhang H, et al. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012 Jun;19(6):396–403.
   PubMed Web of Science ®Google Scholar
• Zhang F, Fan YC, Mu NN, et al. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection. J Viral Hepat. 2014 Apr;21(4):241–250.
   PubMed Web of Science ®Google Scholar
• Fan YC, Wang N, Sun YY, et al. TIPE2 mRNA level in PBMCs serves as a novel biomarker for predicting short-term mortality of acute-on-chronic hepatitis B liver failure: A prospective single-center study. Medicine. 2015 Sep;94(39):e1638.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018 Dec;15(12):738–752.
   PubMed Web of Science ®Google Scholar
• Qin B, Wei T, Wang L, et al. Decreased expression of TIPE2 contributes to the hyperreactivity of monocyte to Toll-like receptor ligands in primary biliary cirrhosis. J Gastroenterol Hepatol. 2016 Jun;31(6):1177–1183.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang Y, Zhou J, et al. Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response. Tumour Biol. 2016 Nov;37(11):15265–15274.
   PubMedGoogle Scholar
• McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009 May;49(5):S45–S55.
   PubMed Web of Science ®Google Scholar